Restart Life Sciences Corp. (CSE:HEAL)

Market Cap	4.69M +44.5%
Revenue (ttm)	465.72K
Net Income	-1.71M
EPS	-0.04
Shares Out	62.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,012
Open	0.0750
Previous Close	0.0750
Day's Range	0.0750 - 0.0750
52-Week Range	0.0700 - 0.1350
Beta	-0.80
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba’s Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the development across various product lines, including BrainQ, BrainBalls, and Hol...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: HEAL

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error